# Dose Finding Trial of MK-7075 in Children and Adults With Proteus Syndrome

> **NCT02594215** · PHASE1 · COMPLETED · sponsor: **National Human Genome Research Institute (NHGRI)** · enrollment: 6 (actual)

## Conditions studied

- Proteus Syndrome

## Interventions

- **DRUG:** MK-7075 (miransertib)

## Key facts

- **NCT ID:** NCT02594215
- **Lead sponsor:** National Human Genome Research Institute (NHGRI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11-16
- **Primary completion:** 2017-12-31
- **Final completion:** 2022-06-24
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2022-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02594215

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02594215, "Dose Finding Trial of MK-7075 in Children and Adults With Proteus Syndrome". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT02594215. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*